TOMBERLI, BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.042
EU - Europa 723
AS - Asia 174
SA - Sud America 2
Totale 1.941
Nazione #
US - Stati Uniti d'America 1.041
PL - Polonia 374
IT - Italia 106
IE - Irlanda 101
SE - Svezia 95
CN - Cina 51
JO - Giordania 37
HK - Hong Kong 34
SG - Singapore 23
RU - Federazione Russa 17
VN - Vietnam 14
IR - Iran 9
GB - Regno Unito 7
FI - Finlandia 5
DE - Germania 4
FR - Francia 4
CH - Svizzera 3
AR - Argentina 2
ES - Italia 2
JP - Giappone 2
TR - Turchia 2
UA - Ucraina 2
BE - Belgio 1
CA - Canada 1
GR - Grecia 1
KR - Corea 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 1.941
Città #
Warsaw 374
Fairfield 215
Dublin 101
Ashburn 91
Woodbridge 91
Houston 74
Seattle 74
Wilmington 64
Chandler 62
Cambridge 52
Ann Arbor 40
Lawrence 40
Altamura 37
Beijing 26
Princeton 25
Florence 24
Boston 18
Hong Kong 16
New York 16
San Diego 13
Dong Ket 12
Moscow 12
Singapore 12
Shanghai 11
Buffalo 10
Medford 10
Norwalk 7
Tehran 7
Boardman 5
Nanjing 5
Cagliari 4
Andover 3
Bern 3
Dearborn 3
Jacksonville 3
Rome 3
Barcelona 2
Bologna 2
Buenos Aires 2
Fuzhou 2
Hillsboro 2
Kent 2
Lecce 2
Milan 2
Phoenix 2
Scarperia e San Piero 2
Vicenza 2
Washington 2
Acton 1
Adelfia 1
Aigaleo 1
Aquila 1
Bethesda 1
Brusciano 1
Brussels 1
Cutrofiano 1
Esslingen am Neckar 1
Falls Church 1
Genova 1
Hangzhou 1
Hefei 1
Helsinki 1
Izmir 1
Jinan 1
Košice 1
London 1
Mirano 1
Modugno 1
Monterotondo 1
Nagold 1
Old Bridge 1
Omsk 1
Prescot 1
Redmond 1
Redwood City 1
Sabz 1
San Biagio di Callalta 1
Seoul 1
Simi Valley 1
Sinalunga 1
St Petersburg 1
Terricciola 1
Toronto 1
Trumbull 1
Vigliano Biellese 1
Wuhan 1
Totale 1.625
Nome #
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 206
Confronting the archipelago of primary myocardial diseases: from the comprehension of genetic basis, molecular mechanisms and clinical correlates to the development of novel therapeutic approaches. 185
Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy 125
Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy 107
Contemporary genetic testing in inherited cardiac disease: Tools, ethical issues, and clinical applications 103
Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease. 96
Abrupt onset of refractory heart failure associated with light-chain amyloidosis in hypertrophic cardiomyopathy 88
Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients with Hypertrophic Cardiomyopathy 87
Novel α-Actinin 2 Variant Associated With Familial Hypertrophic Cardiomyopathy and Juvenile Atrial Arrhythmias: A Massively Parallel Sequencing Study. 84
Peripheral artery disease and amputations with Sodium-Glucose co-Transporter-2 (SGLT-2) inhibitors: A meta-analysis of randomized controlled trials 82
Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy 76
Defining phenotypes and disease progression in sarcomeric cardiomyopathies: Contemporary role of clinical investigations 76
Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study 72
Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy 69
Comprehensive Risk Management in Arrhythmogenic Cardiomyopathy Associated With Autosomal Dominant Carvajal Syndrome 67
A Brief History of Coronary Artery Stents 65
Pathophysiology and Treatment of Hypertrophic Cardiomyopathy: New Perspectives 51
EMBOLIC RISK STRATIFICATION ANDPROGNOSTIC IMPACT OF EARLY SURGERY IN LEFT-SIDED INFECTIVE ENDOCARDITIS 49
Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy 49
Lack of Phenotypic Differences by Cardiovascular Magnetic Resonance Imaging in MYH7 (β-Myosin Heavy Chain)- Versus MYBPC3 (Myosin-Binding Protein C)-Related Hypertrophic Cardiomyopathy 46
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 45
Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry 43
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 40
[Clinical relevance of genetic testing in hypertrophic cardiomyopathy]. 31
Terapia anticoagulante e antiaggregante 27
Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations. 2
Totale 1.971
Categoria #
all - tutte 6.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020546 19 22 6 28 51 57 91 82 69 49 65 7
2020/2021383 37 34 19 42 17 37 20 33 30 83 13 18
2021/2022204 16 7 19 2 8 10 10 9 18 19 27 59
2022/2023467 39 106 39 9 14 73 62 25 68 4 21 7
2023/2024164 2 19 25 12 7 29 10 28 6 12 5 9
2024/202523 23 0 0 0 0 0 0 0 0 0 0 0
Totale 1.971